Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03130062
Other study ID # 13041978
Secondary ID
Status Completed
Phase N/A
First received April 16, 2017
Last updated April 25, 2017
Start date January 2014
Est. completion date September 2015

Study information

Verified date April 2017
Source Federal University of São Paulo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To analyze the effectiveness of 16-week resistance exercise in daily motor behavior and functional fitness in women with Primary Sjögren's Syndrome. The present study presents as hypothesis that a supervised resistance exercise program is effective and safe in improving the functional fitness and quality of life of patients with Primary Sjögren's Syndrome, making them more physically active, contributing positively to the capacity to perform daily life activities as household and / or professional tasks.


Description:

Read more »
Read more »

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Exercise
The following muscular clusters were exerted: latissimus dorsi, deltoid, pectoralis major , triceps brachialis, biceps brachialis, quadriceps, hamstring, thigh adductor muscles, thigh abductor muscles and gastrocnemius.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Federal University of São Paulo

References & Publications (15)

See more »

Outcome

Type Measure Description Time frame Safety issue
Primary Change in functional fitness The protocol consists of a sequence of 7 tests that aim to mimic the neuromotor and cardiorespiratory needs involved in the daily life activities. This battrey test was designed and validated to evaluate the elderly without a ceiling effect, ensuring that the physical aspect measured represents the maximum of the individual.
The physiological components evaluated, based on the physical abilities performed in the daily activities are: upper and lower limb strength, aerobic capacity, upper and lower limb flexibility, as well as motor agility / dynamic balance. In addition, the authors added the body mass index (BMI), to estimate the body composition.
The subjects were assessed in 2 moments: before entering the resistance training program and after 16 weeks of intervention.
Primary Change in daily motor activity index To verify the daily movement index of the subjects we used a device called an actigraphy or actimeter. The subjects were assessed for 15 consecutive days belonging to the habitual routine of the volunteers. It was used in 2 moments: before entering the resistance training program and after 16 weeks of intervention.
Secondary Quality of life estimate To evaluate the quality of life, the "Medical Outcomes Study SF-36", a generic questionnaire was translated and validated for the Brazilian population (Ciconelli, 1999). To evaluate, in a generic way, the quality of life. It is a multidimensional instrument composed of 36 items evaluating in 8 dimensions thus distributed: 10 items related to functional capacity; 4 physical appearance items; 2 items on pain; 5 items related to general health status; 4 items on vitality; 2 items with respect to social aspects; 3 items on emotional aspects; 5 items related to mental health and one more question of comparative evaluation between the current health conditions and that of a year ago. The subjects were assessed in 2 moments: before entering the resistance training program and after 16 weeks of intervention.
Secondary Estimates of disease activity ESSDAI - Sjögren's Syndrome Disease Activity Index is a questionnaire that investigates the activity of SSP disease and has 12 domains (constitutional, lymphadenopathy, glandular, articular, cutaneous, respiratory, renal, muscular, peripheral nervous system, central nervous system, hematological, biological) (Seror et al. 2009). It was developed from a consensus study of the EULAR (European League Against Rheumatism) and the American group. His cross-cultural adaptation and validity for the Brazilian Portuguese language was performed by the Sjögren's syndrome clinic of the Rheumatology department of the Cassiano Antônio de Moraes University Hospital (HUCAM), in Vitória, Espírito Santo (Serrano et al., 2013). Disease activity is classified into 3 levels: mildly active, moderately active and highly active. The subjects were assessed in 2 moments: before entering the resistance training program and after 16 weeks of intervention.
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06440525 - A Phase 2 Study of RSLV-132 in Females With Primary Sjögren's Syndrome Phase 2
Not yet recruiting NCT03140111 - LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients N/A
Not yet recruiting NCT06049368 - 68Ga-P16-093 PET/CT Imaging in the Salivary Gland Phase 1/Phase 2
Not yet recruiting NCT03614299 - Eye Dryness Evaluation in Primary Sjögren's Syndrome
Not yet recruiting NCT03126383 - Inflammatory Myopathies in Primary Sjögren's Syndrome N/A
Recruiting NCT04830644 - A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome. Phase 2
Not yet recruiting NCT03765593 - Biomarkers in Primary Sjögren's Syndrome
Completed NCT01081184 - Neurotrophins Implications in Primary Sjögren Syndrome N/A
Completed NCT05670535 - Sjögren and Gynecologic Considerations
Completed NCT03226444 - Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome Phase 1/Phase 2
Completed NCT04816370 - Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions N/A
Completed NCT05380804 - Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
Terminated NCT04700280 - A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS) Phase 2
Completed NCT04093531 - Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome Phase 1
Recruiting NCT03509064 - Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
Completed NCT04224454 - Vaccine Coverage and Primary Sjögren'Syndrome
Completed NCT04960605 - Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome N/A
Recruiting NCT06361745 - Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases N/A